Variable | Tertiles of the insulinemic indices | |||
---|---|---|---|---|
1 | 2 | 3 | P-trend | |
EDIH | ||||
 EDIH value cut points | <0.128 | 0.128 to 0.259 | >0.259 |  |
 Median score | 0.064 | 0.198 | 0.373 |  |
 cancer /control | 28/88 | 56/89 | 49/88 |  |
 Crude | Ref (1.00) | 1.95 (1.14 – 3.36) | 1.73 (1.00 – 3.00) | 0.094 |
 Model 1a | Ref (1.00) | 2.00 (1.16 – 3.47) | 2.85 (1.05 – 3.23) | 0.059 |
 Model 2b | Ref (1.00) | 1.80 (1.03 – 3.17) | 1.81 (1.02 – 3.23) | 0.068 |
 Model 3c | Ref (1.00) | 2.00 (1.12 – 3.6) | 2.24 (1.21 – 4.12) | 0.016 |
EDIR | ||||
 EDIR value cut points | <0.733 | 0.733 to 1.044 | >1.044 |  |
 Median score | 0.578 | 0.867 | 1.288 |  |
 cancer /control | 51/88 | 44/89 | 38/88 |  |
 Crude | Ref (1.00) | 0.84 (0.51 – 1.39) | 0.74 (0.44 – 1.25) | 0.265 |
 Model 1a | Ref (1.00) | 0.86 (0.52 – 1.43) | 0.74 (0.44 – 1.25) | 0.259 |
 Model 2b | Ref (1.00) | 0.87 (0.52 – 1.46) | 0.76 (0.44 – 1.30) | 0.318 |
 Model 3c | Ref (1.00) | 0.90 (0.57 – 1.54) | 0.94 (0.51 – 1.74) | 0.846 |
ELIH | ||||
 ELIH value cut points | <1.302 | 1.302 to 1.586 | >1.586 |  |
 Median score | 1.170 | 1.452 | 1.786 |  |
 cancer /control | 33/87 | 53/87 | 47/86 |  |
 Crude | Ref (1.00) | 1.58 (0.93 – 2.68) | 1.46 (0.85 – 2.49) | 0.206 |
 Model 1a | Ref (1.00) | 1.50 (0.88 – 2.55) | 1.40 (0.80 – 2.39) | 0.287 |
 Model 2b | Ref (1.00) | 1.56 (0.90 – 2.71) | 1.49 (0.85 – 2.61) | 0.202 |
 Model 3d | Ref (1.00) | 1.50 (0.86 – 2.62) | 1.43 (0.81 – 2.53) | 0.255 |
ELIR | ||||
 ELIR value cut points | <4.543 | 4.543 to 6.486 | >6.486 |  |
 Median score | 3.882 | 5.420 | 7.761 |  |
 cancer /control | 39/87 | 57/88 | 37/87 |  |
 Crude | Ref (1.00) | 1.42 (0.86 – 2.35) | 0.96 (0.56 – 1.45) | 0.732 |
 Model 1a | Ref (1.00) | 1.41 (0.85 – 2.34) | 0.97 (0.56 – 1.67) | 0.754 |
 Model 2b | Ref (1.00) | 1.48 (0.88 – 2.51) | 1.03 (0.58 – 1.81) | 0.913 |
 Model 3d | Ref (1.00) | 1.65 (0.96 – 2.83) | 1.29 (0.69 – 2.38) | 0.527 |